Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractLectins are proteins found in all domains of life with a plethora of biological functions, especially in the infection process, immune response, and inflammation. Targeting these carbohydrate-binding proteins is challenged by the fact that usually low affinity interactions between lectin and glycoconjugate are observed. Nature often circumvents this process through multivalent display of ligand and lectin. Consequently, the vast majority of synthetic antagonists are multivalently displayed native carbohydrates. At the cost of disadvantageous pharmacokinetic properties and possibly a reduced selectivity for the target lectin, the molecules usually possess very high affinities to the respective lectin through ligand epitope avidity. Recent developments include the advent of glycomimetic or allosteric small molecule inhibitors for this important protein class and their use in chemical biology and drug research. This evolution has culminated in the transition of the small molecule GMI-1070 into clinical phase III. In this opinion article, an overview of the most important developments of lectin antagonists in the last two decades with a focus on the last five years is given
CitationCurr Opin Chem Biol. 2019 Aug 27;53:51-67. doi: 10.1016/j.cbpa.2019.07.005.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- [Human lectins and their correspondent glycans in cell biology and clinical medicine].
- Authors: Köttgen E, Reutter W, Tauber R
- Issue date: 2003 Dec 15
- Multivalent lectin-carbohydrate interactions energetics and mechanisms of binding.
- Authors: Dam TK, Brewer CF
- Issue date: 2010
- Probing Multivalent Protein-Carbohydrate Interactions by Quantum Dot-Förster Resonance Energy Transfer.
- Authors: Guo Y, Bruce Turnbull W, Zhou D
- Issue date: 2018
- Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface.
- Authors: Porkolab V, Pifferi C, Sutkeviciute I, Ordanini S, Taouai M, Thépaut M, Vivès C, Benazza M, Bernardi A, Renaudet O, Fieschi F
- Issue date: 2020 Jul 1
- Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes.
- Authors: Hauck D, Joachim I, Frommeyer B, Varrot A, Philipp B, Möller HM, Imberty A, Exner TE, Titz A
- Issue date: 2013 Aug 16